HPV and cervical cancer: updates on an established relationship
- PMID: 19020360
- DOI: 10.3810/pgm.2008.11.1928
HPV and cervical cancer: updates on an established relationship
Abstract
Despite cervical cancer being considered a preventable disease, it still remains the second most common malignancy in women worldwide, with a higher incidence in underdeveloped countries. Human papillomavirus (HPV) is considered the causative agent of cervical cancer. The major mechanisms through which HPV contributes to neoplastic initiation and progression include the activity of 2 viral oncoproteins, E6 and E7, which interfere with critical cell cycle tumor suppressive proteins, p53 and retinoblastoma (Rb) protein. However, HPV infection alone is not sufficient to induce malignant transformation, and other significant cofactors contribute to the multi-step process of tumor formation, such as individual genetic variations as well as environmental factors. However, these cofactors are not important in the absence of HPV. Papanicolaou testing (Pap smear) and HPV DNA testing are tools used in the screening and diagnosis of cervical neoplastic lesions. Vaccination against HPV appears to be cost-effective in the prevention of HPV infection. A thorough understanding of the mechanisms that underline HPV carcinogenesis may result in the development of sophisticated targeted therapeutic approaches, such as antisense oligonucleotides against HPV oncoproteins.
Similar articles
-
Vaccines against human papillomavirus and cervical cancer: promises and challenges.Oncologist. 2005 Aug;10(7):528-38. doi: 10.1634/theoncologist.10-7-528. Oncologist. 2005. PMID: 16079320 Review.
-
Role of human papilloma virus testing in cervical cancer prevention.J Midwifery Womens Health. 2004 Jan-Feb;49(1):4-13. doi: 10.1016/j.jmwh.2003.10.002. J Midwifery Womens Health. 2004. PMID: 14710135
-
Human papillomavirus in cervical screening and vaccination.Clin Sci (Lond). 2006 May;110(5):543-52. doi: 10.1042/CS20050230. Clin Sci (Lond). 2006. PMID: 16597323 Review.
-
Human papillomavirus testing for primary cervical cancer screening.Expert Rev Mol Diagn. 2008 Sep;8(5):599-605. doi: 10.1586/14737159.8.5.599. Expert Rev Mol Diagn. 2008. PMID: 18785808 Review.
-
Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.Rev Med Virol. 2009 Mar;19(2):97-113. doi: 10.1002/rmv.605. Rev Med Virol. 2009. PMID: 19156753 Review.
Cited by
-
Prediction of Patient Outcomes in Locally Advanced Cervical Carcinoma Following Chemoradiotherapy-Comparative Effectiveness of Magnetic Resonance Imaging and 2-Deoxy-2-[18F]fluoro-D-glucose Imaging.Cancers (Basel). 2024 Jan 23;16(3):476. doi: 10.3390/cancers16030476. Cancers (Basel). 2024. PMID: 38339229 Free PMC article.
-
Cdc25B is transcriptionally inhibited by IER5 through the NF-YB transcription factor in irradiation-treated HeLa cells.Toxicol Res (Camb). 2021 Jul 29;10(4):875-884. doi: 10.1093/toxres/tfab069. eCollection 2021 Aug. Toxicol Res (Camb). 2021. PMID: 34484679 Free PMC article.
-
Risk factors for precancerous cervical lesion among women screened for cervical cancer in south Ethiopia: Unmatched case-control study.PLoS One. 2021 Jul 15;16(7):e0254663. doi: 10.1371/journal.pone.0254663. eCollection 2021. PLoS One. 2021. PMID: 34265004 Free PMC article.
-
Epidermal growth factor receptor regulates fibrinolytic pathway elements in cervical cancer: functional and prognostic implications.Braz J Med Biol Res. 2021 Apr 19;54(6):e10754. doi: 10.1590/1414-431X202010754. eCollection 2021. Braz J Med Biol Res. 2021. PMID: 33886813 Free PMC article.
-
An audit of the cervical screening programme in the National Drug Treatment Centre (NDTC).Ir J Med Sci. 2021 Nov;190(4):1379-1386. doi: 10.1007/s11845-020-02459-1. Epub 2021 Jan 15. Ir J Med Sci. 2021. PMID: 33449334 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous